Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Biogen Inc
NASDAQ:BIIB
Biogen Inc
NASDAQ:BIIB
Price:
222.06
USD
-0.34%
Market Cap:
$32.8B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Biogen Inc
NASDAQ:BIIB
|
US |
|
Imricor Medical Systems Inc
ASX:IMR
|
US |
|
BeOne Medicines AG
F:49BA
|
CH |
|
Hochschild Mining PLC
OTC:HCHDY
|
UK |
|
H
|
Ho Chi Minh City Development Joint Stock Commercial Bank
VN:HDB
|
VN |
|
D
|
Duke Energy Corp
F:D2MN
|
US |
|
M
|
Montana Aerospace AG
SIX:AERO
|
CH |
|
Lingerie Fighting Championships Inc
OTC:BOTY
|
US |
|
M
|
Metcash Ltd
OTC:MCSHF
|
AU |
|
K
|
Kawasaki & Co Ltd
TSE:3045
|
JP |
|
Vardhman Textiles Ltd
NSE:VTL
|
IN |
|
United Natural Foods Inc
NYSE:UNFI
|
US |
|
Tata Consultancy Services Ltd
NSE:TCS
|
IN |
|
Dentsu Group Inc
F:DEN0
|
JP |
|
Enovix Corp
NASDAQ:ENVX
|
US |
Wall St Price Targets
BIIB Price Forecast
Based on 34 analysts
Based on 34 analysts
+10% Upside
from
$222.06
today
Biogen Inc (BIIB)’s 12-month stock price forecast through October 2027 has a consensus target of $244.8, implying 10% upside. The forecast is based on price targets from 34 Wall Street analysts.
BIIB Analyst Rating
Based on 37 analysts
Based on 37 analysts
Analysts rate BIIB Buy, with 17 of 37 recommending Buy or Strong buy.
Biogen Inc Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is BIIB's stock price target?
Price Target
244.8
USD
244.8
USD
According to Wall Street analysts, the average 1-year price target for BIIB is 244.8 USD with a low forecast of 176.75 USD and a high forecast of 315 USD.
What is the Revenue forecast for Biogen Inc?
Projected CAGR
2%
2%
Over the last 13 years, the compound annual growth rate for Revenue has been 5%. The projected CAGR for the next 8 years is 2%.
What is the Gross Profit forecast for Biogen Inc?
Projected CAGR
3%
3%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 3%. The projected CAGR for the next 8 years is 3%.
What is the Operating Income forecast for Biogen Inc?
Projected CAGR
6%
6%
Over the last 13 years, the compound annual growth rate for Operating Income has been 2%. The projected CAGR for the next 8 years is 6%.
What is the Pre-Tax Income forecast for Biogen Inc?
Projected CAGR
29%
29%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been -1%. The projected CAGR for the next 3 years is 29%.
What is the Net Income forecast for Biogen Inc?
Projected CAGR
14%
14%
Over the last 13 years, the compound annual growth rate for Net Income has been -1%. The projected CAGR for the next 8 years is 14%.